Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Charles B Davis

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Journal of Pharmaceutical Sciences|June 20, 2008
Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarialsCharles B Davis, Ramesh Bambal, Ganesh S Moorthy, et al.
Toxicologic Pathology|July 10, 2010
Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicityKevin J French, Robert W Coatney, Jon P Renninger, et al.
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Journal of Medicinal Chemistry|April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted CancersKevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta InhibitorsHong Lin, Mark J Schulz, Ren Xie, et al.
Journal of Medicinal Chemistry|February 19, 2009
Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st centuryPaul M O'Neill, B Kevin Park, Alison E Shone, et al.
Journal of Medicinal Chemistry|March 17, 2009
Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquinePaul M O'Neill, Alison E Shone, Deborah Stanford, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Journal of Pharmaceutical Sciences|June 20, 2008
Comparative preclinical drug metabolism and pharmacokinetic evaluation of novel 4-aminoquinoline anti-malarialsCharles B Davis, Ramesh Bambal, Ganesh S Moorthy, et al.
Toxicologic Pathology|July 10, 2010
Differences in effects on myocardium and mitochondria by angiogenic inhibitors suggest separate mechanisms of cardiotoxicityKevin J French, Robert W Coatney, Jon P Renninger, et al.
The Journal of Rheumatology|February 13, 2002
CD4 coating, but not CD4 depletion, is a predictor of efficacy with primatized monoclonal anti-CD4 treatment of active rheumatoid arthritisUrsula Mason, Jose Aldrich, Ferdinand Breedveld, et al.
Journal of Medicinal Chemistry|April 10, 2024
Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with <i>MTAP</i>-Deleted CancersKevin M Cottrell, Kimberly J Briggs, Douglas A Whittington, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Rational Design, Synthesis, and SAR of a Novel Thiazolopyrimidinone Series of Selective PI3K-beta InhibitorsHong Lin, Mark J Schulz, Ren Xie, et al.
Journal of Medicinal Chemistry|February 19, 2009
Candidate selection and preclinical evaluation of N-tert-butyl isoquine (GSK369796), an affordable and effective 4-aminoquinoline antimalarial for the 21st centuryPaul M O'Neill, B Kevin Park, Alison E Shone, et al.
Journal of Medicinal Chemistry|March 17, 2009
Synthesis, antimalarial activity, and preclinical pharmacology of a novel series of 4'-fluoro and 4'-chloro analogues of amodiaquine. Identification of a suitable "back-up" compound for N-tert-butyl isoquinePaul M O'Neill, Alison E Shone, Deborah Stanford, et al.
Pageof 2